drugset / Trial / NCT01828177

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

NCT01828177 ↗

Phase 2 Unknown 200 enrolled PreCision Dermatology, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

This 4-arm Phase 2 vehicle-controlled study is designed to assess the safety and efficacy of PDI-320, and the individual components, in adult subjects with rosacea.

Timeline

Start
2013-06
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PDI-320 Unknown — —
Subject PDI-320 Monad #1 Unknown — —
Subject PDI-320 Monad #2 Unknown — —

Indications